Alessandra Bracigliano

662 total citations
17 papers, 432 citations indexed

About

Alessandra Bracigliano is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Alessandra Bracigliano has authored 17 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Alessandra Bracigliano's work include Liver Disease Diagnosis and Treatment (6 papers), Liver Disease and Transplantation (4 papers) and Neuroendocrine Tumor Research Advances (2 papers). Alessandra Bracigliano is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Liver Disease and Transplantation (4 papers) and Neuroendocrine Tumor Research Advances (2 papers). Alessandra Bracigliano collaborates with scholars based in Italy, Switzerland and Japan. Alessandra Bracigliano's co-authors include Paolo Sorrentino, R Vecchione, Salvatore D’Angelo, Umberto Ferbo, Pietro Micheli, Luigi Terracciano, Luciano Tarantino, O. Perrella, Alessandro Perrella and Salvatore Tafuto and has published in prestigious journals such as Journal of Hepatology, Annals of Oncology and The American Journal of Gastroenterology.

In The Last Decade

Alessandra Bracigliano

16 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandra Bracigliano Italy 9 273 179 75 73 54 17 432
Kota Tsuruya Japan 13 175 0.6× 206 1.2× 99 1.3× 40 0.5× 77 1.4× 46 408
Naotaka Shimozato Japan 13 177 0.6× 158 0.9× 58 0.8× 36 0.5× 26 0.5× 34 342
Takehisa Suekane Japan 11 137 0.5× 72 0.4× 100 1.3× 42 0.6× 88 1.6× 28 401
Elisabetta Morello Italy 8 232 0.8× 128 0.7× 58 0.8× 35 0.5× 29 0.5× 15 381
Shigeo Maruyama Japan 9 188 0.7× 182 1.0× 58 0.8× 13 0.2× 46 0.9× 25 378
Ryuji FURUKAWA Japan 11 357 1.3× 313 1.7× 74 1.0× 109 1.5× 55 1.0× 31 535
Hirohisa Shigematsu Japan 15 402 1.5× 400 2.2× 85 1.1× 24 0.3× 45 0.8× 28 645
Daisuke Miyaki Japan 15 282 1.0× 381 2.1× 137 1.8× 50 0.7× 64 1.2× 24 505
Dieter Lederer Austria 3 183 0.7× 57 0.3× 23 0.3× 49 0.7× 41 0.8× 5 272
Sukhwinderjit Lidder United Kingdom 7 210 0.8× 228 1.3× 105 1.4× 30 0.4× 43 0.8× 8 494

Countries citing papers authored by Alessandra Bracigliano

Since Specialization
Citations

This map shows the geographic impact of Alessandra Bracigliano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Bracigliano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Bracigliano more than expected).

Fields of papers citing papers by Alessandra Bracigliano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Bracigliano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Bracigliano. The network helps show where Alessandra Bracigliano may publish in the future.

Co-authorship network of co-authors of Alessandra Bracigliano

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Bracigliano. A scholar is included among the top collaborators of Alessandra Bracigliano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Bracigliano. Alessandra Bracigliano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bracigliano, Alessandra, et al.. (2025). FAP-α in soft tissue and bone sarcomas: A new potential diagnostic and therapeutic biomarker in the era of precision medicine. Critical Reviews in Oncology/Hematology. 215. 104852–104852.
2.
Bracigliano, Alessandra, Luigi Pio Guerrera, Vincenza Granata, et al.. (2024). The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives. Pharmaceuticals. 17(3). 354–354. 5 indexed citations
3.
Arx, Claudia von, Giuseppina Della Vittoria Scarpati, L. Cannella, et al.. (2024). A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial. ESMO Open. 9(5). 103003–103003. 3 indexed citations
4.
Ottaiano, Alessandro, Alessandra Bracigliano, Francesca Di Gennaro, et al.. (2023). Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 12(4). 1494–1494. 13 indexed citations
6.
Cannella, L., Francesco Perri, Claudia von Arx, et al.. (2022). The Complex Management of the Breast Angiosarcoma: A Retrospective Study. Oncology. 101(4). 234–239. 3 indexed citations
7.
Cives, Mauro, Alessandra Bracigliano, Eleonora Pellè, et al.. (2021). The psychological impact of COVID‐19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability. Journal of Neuroendocrinology. 33(10). e13041–e13041. 4 indexed citations
9.
Bracigliano, Alessandra, Fabiana Tatangelo, Francesco Perri, et al.. (2021). Malignant Sinonasal Tumors: Update on Histological and Clinical Management. Current Oncology. 28(4). 2420–2438. 27 indexed citations
10.
Ottaiano, Alessandro, Alessandra Bracigliano, L. Cannella, et al.. (2021). Is immunotherapy in the future of therapeutic management of sarcomas?. Journal of Translational Medicine. 19(1). 173–173. 23 indexed citations
11.
Sorrentino, Paolo, Giuseppe Castaldo, Luciano Tarantino, et al.. (2011). Preservation of nutritional‐status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis. Journal of Gastroenterology and Hepatology. 27(4). 813–822. 43 indexed citations
12.
Sorrentino, Paolo, Luigi Terracciano, Salvatore D’Angelo, et al.. (2010). Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis. Journal of Gastroenterology. 45(10). 1053–1062. 37 indexed citations
13.
Sorrentino, Paolo, Luciano Tarantino, Salvatore D’Angelo, et al.. (2010). Validation of an extension of the international non‐invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis. Journal of Gastroenterology and Hepatology. 26(4). 669–677. 19 indexed citations
14.
Sorrentino, Paolo, Luigi Terracciano, Salvatore D’Angelo, et al.. (2009). Predicting Fibrosis Worsening in Obese Patients With NASH Through Parenchymal Fibronectin, HOMA-IR, and Hypertension. The American Journal of Gastroenterology. 105(2). 336–344. 65 indexed citations
15.
Sorrentino, Paolo, Salvatore D’Angelo, Luciano Tarantino, et al.. (2009). Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients. World Journal of Gastroenterology. 15(18). 2245–2245. 32 indexed citations
16.
Sorrentino, Paolo, Salvatore D’Angelo, Umberto Ferbo, et al.. (2008). Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. Journal of Hepatology. 50(2). 351–357. 146 indexed citations
17.
Caprio, Maria Grazia, Giuseppe Carbone, Alessandra Bracigliano, et al.. (2002). Sentinel Lymph Node Detection by Lymphoscintigraphy in Malignant Melanoma. Tumori Journal. 88(3). S43–S45. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026